A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits

Br J Ophthalmol. 1982 May;66(5):303-8. doi: 10.1136/bjo.66.5.303.

Abstract

Cyclosporin-A (CyA) administered to rabbits intramuscularly in a dose of 25 mg/kg/day for 14 days following interlamellar corneal grafting had a significant effect in preventing rejection of the corneal graft (p less than 0.05), and the benefit was maintained. Rejection was attended by an initial mild inflammatory reaction and followed by a protracted intense response involving a variety of cell types, with subsequent loss of epithelium. endothelium and keratocytes, and the development of areas of stromal necrosis. CyA suppressed this rejection response.

MeSH terms

  • Animals
  • Cornea / drug effects
  • Cornea / pathology
  • Corneal Transplantation*
  • Cyclosporins / therapeutic use*
  • Drug Evaluation, Preclinical
  • Graft Rejection / drug effects*
  • Rabbits

Substances

  • Cyclosporins